• In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.

  • In this blog I discuss a recent publication (Davis et al, 2020) which looked at a novel treatment for depression: Psilocybin. I review the study, look at the outcomes, and consider what the implications might be for treatment.

  • Most of us will consume caffeine in some form, but what if it could reduce symptoms of OCD? A recent study (Naftalovich et al, 2020) explored whether caffeine could help inhibition - which includes the ability to suppress or change intrusive thoughts. Here, we look at this study to see whether caffeine might be therapeutically helpful.